IMDX Insight Molecular Diagnostics Inc.
NASDAQActiveCommon stock
IMDX is the ticker symbol of Insight Molecular Diagnostics Inc., which is listed on NASDAQ.
IMDX at a glance
- Symbol
- IMDX
- Company / issuer
- Insight Molecular Diagnostics Inc.
- Security type
- Common stock
- Exchange
- NASDAQ
- Status
- Actively traded
- Seen in listing files
- Jun 2025 – present
- Sector
- Health Care
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Country
- United States
- Market cap
- $129.3 million (Sep 2026)
Insight Molecular Diagnostics Inc. company profile
- Industry (SIC)
- In Vitro & In Vivo Diagnostic Substances
- Headquarters
- Nashville, TN
- Incorporated in
- CA
- Fiscal year end
- December 31
- SEC filer category
- Non-accelerated filer<br>Smaller reporting company
- Latest annual report
- 10-K filed 2026-03-26
- Latest interim report
- 10-Q filed 2026-08-10
- SEC CIK
- 1642380
Former company names
- OncoCyte Corp (until 2025)
- Oncocyte Corp (until 2025)
Source: SEC EDGAR filer data.
IMDX price chart
Interactive chart provided by TradingView (loads third-party scripts).
Frequently asked questions
What company has the ticker symbol IMDX?
IMDX is the ticker symbol of Insight Molecular Diagnostics Inc on NASDAQ.
Is IMDX still trading?
Yes. IMDX appears in the current NASDAQ listings as of Sep 2026.
Which exchange is IMDX listed on?
IMDX is listed on NASDAQ.
Nearby symbols
IMAQ International Media Acquisition Corp.IMAX Imax CorporationIMC IMC Rare Earths LtdIMCC IM Cannabis Corp.IMCI Infinite Group Inc.IMCR Immunocore Holdings plcIMDZ Immune Design Corp.IMGN ImmunoGen Inc.IMI Intermolecular, Inc.IMIMF Interra Copper Corp.IMKTA Ingles Markets, IncorporatedIMMP Immutep Limited